Regulation, Reimbursement Notes From Thailand
This article was originally published in PharmAsia News
Thailand struggles to tackle reimbursement reforms as political tension grips the country following a military coup last week. Still the civil service continues to take decisions on budget and spending plans, but domestic and multinational firms are keeping a wary eye on developments.
You may also be interested in...
Thailand’s military junta has made few moves to tackle reimbursement reforms since a coup in May. But the appointment of a cabinet this month may signal action on health care spending levels.
Thai Researchers, MMV Launch Preclinical Look For New Anti-Malaria Compound Targeting Mutant Enzymes
Research into anti-malarial drug effectiveness in Thailand prompts a pre-clinical look at novel compound.
Thailand’s public health system faces the same pangs of civil discord as the fractured political system. Opposition politicians are calling on civil servants to openly disobey an order from Prime Minister Yingluck Shinawatra on a key plank of her government, health care for the poor.